Please ensure Javascript is enabled for purposes of website accessibility

Coronado Biosciences Names New CEO

By Eric Volkman - Dec 20, 2013 at 6:03PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Coronado Biosciences taps Lindsay Rosenwald to lead the company.

Coronado Biosciences (FBIO 4.12%) has effected a top-level leadership change. The company announced it has appointed Lindsay Rosenwald as its new chairman, president, and CEO, effective yesterday. He replaces outgoing Chairman and CEO Harlan Weisman. 

Rosenwald is not a stranger to the company, having served on its board of directors since 2009. Previous to being tapped to lead the firm, he was a partner and co-portfolio manager of health care-focused asset management firm Opus Point Partners. Prior to that, he was chairman of investment company Paramount BioCapital from 1991 to 2008.

Rosenwald was not the only new hire announced by the company. Coronado has also drafted his Opus co-founder and fellow portfolio manager Michael Weiss to serve on the board as vice-chairman.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Fortress Biotech, Inc. Stock Quote
Fortress Biotech, Inc.
$0.83 (4.12%) $0.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.